MXPA05010708A - Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel. - Google Patents

Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel.

Info

Publication number
MXPA05010708A
MXPA05010708A MXPA05010708A MXPA05010708A MXPA05010708A MX PA05010708 A MXPA05010708 A MX PA05010708A MX PA05010708 A MXPA05010708 A MX PA05010708A MX PA05010708 A MXPA05010708 A MX PA05010708A MX PA05010708 A MXPA05010708 A MX PA05010708A
Authority
MX
Mexico
Prior art keywords
immunosuppressant
treatment
pharmaceutical composition
skin diseases
desoxyascomycin
Prior art date
Application number
MXPA05010708A
Other languages
English (en)
Inventor
Paul Carle
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MXPA05010708A publication Critical patent/MXPA05010708A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere a combinaciones sinergicas de un macrolido inmunomodulador o inmunosupresor de celulas T, tal como 33-epicloro-33-deseoxiascomicina, y un emoliente tal como dimeticona, glicerol o isoestearato de isoestearilo, las cuales son utiles, en particular, en el tratamiento de enfermedades dermatologicas o mucosales, tales como la piel seca o la dermatitis atopica o dermatitis por contacto.
MXPA05010708A 2003-04-04 2004-04-02 Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel. MXPA05010708A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307866.4A GB0307866D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003513 WO2004087141A1 (en) 2003-04-04 2004-04-02 Pharmaceutical composition comprising an immunosuppressant for use in the treatment of skin diseases

Publications (1)

Publication Number Publication Date
MXPA05010708A true MXPA05010708A (es) 2005-12-12

Family

ID=9956229

Family Applications (2)

Application Number Title Priority Date Filing Date
MXPA05010703A MXPA05010703A (es) 2003-04-04 2004-04-02 Composicion farmaceutica que comprende un inmunosupreror para usarse en el tratamiento de enfermedades de la piel.
MXPA05010708A MXPA05010708A (es) 2003-04-04 2004-04-02 Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MXPA05010703A MXPA05010703A (es) 2003-04-04 2004-04-02 Composicion farmaceutica que comprende un inmunosupreror para usarse en el tratamiento de enfermedades de la piel.

Country Status (13)

Country Link
US (1) US20070276004A1 (es)
EP (1) EP1613314A1 (es)
JP (1) JP2006522059A (es)
CN (1) CN1767826A (es)
AU (1) AU2004226821A1 (es)
BR (1) BRPI0409187A (es)
CA (1) CA2521250A1 (es)
GB (1) GB0307866D0 (es)
IS (1) IS8105A (es)
MX (2) MXPA05010703A (es)
NO (1) NO20055136L (es)
RS (1) RS20050739A (es)
WO (1) WO2004087141A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0506139D0 (en) * 2005-03-24 2005-05-04 Transphase Ltd A transdermal topical composition and its uses
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
EP1948296B2 (en) 2005-10-14 2017-10-11 Pacesetter, Inc. Leadless cardiac pacemaker and system
US10265265B2 (en) 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP2016935A1 (en) * 2007-07-09 2009-01-21 Intendis GmbH Pharmaceutical composition for topical application of poorly soluble compounds
US8527068B2 (en) 2009-02-02 2013-09-03 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
US8543205B2 (en) 2010-10-12 2013-09-24 Nanostim, Inc. Temperature sensor for a leadless cardiac pacemaker
EP2627406A1 (en) 2010-10-13 2013-08-21 Nanostim, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
WO2012082735A1 (en) 2010-12-13 2012-06-21 Nanostim, Inc. Delivery catheter systems and methods
EP2651502B1 (en) 2010-12-13 2016-11-09 Pacesetter, Inc. Pacemaker retrieval systems
US9242102B2 (en) 2010-12-20 2016-01-26 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
EP2680816A1 (en) * 2011-03-03 2014-01-08 Allergan, Inc. Non-aqueous silicone-based ophthalmic formulations
EP2773416B1 (en) 2011-11-04 2019-04-24 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
WO2014022661A1 (en) 2012-08-01 2014-02-06 Nanostim, Inc. Biostimulator circuit with flying cell
EP3273938B8 (de) * 2015-03-25 2020-12-23 GCT GmbH Kosmetisches produkt sowie konzentrat zur herstellung des kosmetischen produktes
CN109069418A (zh) * 2016-04-04 2018-12-21 药品配送方案有限公司 包含他克莫司的局部组合物
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate
CN118317761A (zh) * 2021-12-16 2024-07-09 宝洁公司 毛发调理组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
PL184750B1 (pl) * 1994-10-26 2002-12-31 Novartis Ag Kompozycja w postaci emulsji do stosowania miejscowego
GB2327610B (en) * 1994-11-04 1999-06-02 Novartis Ag Macrolide compositions
AU705320B2 (en) * 1995-12-28 1999-05-20 Welfide Corporation 2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol or a pharmaceutically acceptable acid addition salt thereof for use in the preparation of a non-oral medicament, and for treatment of diseases and disorders
GB9601120D0 (en) * 1996-01-19 1996-03-20 Sandoz Ltd Organic compounds
EP1014916B2 (de) * 1997-08-18 2011-06-15 Neubourg Skin Care GmbH & Co. KG Schaum-hautschutzcreme
SI1064942T1 (en) * 1998-03-26 2004-12-31 Fujisawa Pharmaceutical Co., Ltd. Sustained release preparation of a macrolide
GB9826656D0 (en) * 1998-12-03 1999-01-27 Novartis Ag Organic compounds
JP2001064164A (ja) * 1999-06-23 2001-03-13 Health Science Center:Kk 止痒皮膚塗布剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
AR038628A1 (es) * 2002-03-04 2005-01-19 Novartis Ag Composicion oftalmica
GB0218996D0 (en) * 2002-08-14 2002-09-25 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
CN1767826A (zh) 2006-05-03
IS8105A (is) 2005-10-31
JP2006522059A (ja) 2006-09-28
MXPA05010703A (es) 2005-12-12
BRPI0409187A (pt) 2006-04-11
NO20055136D0 (no) 2005-11-02
GB0307866D0 (en) 2003-05-14
EP1613314A1 (en) 2006-01-11
WO2004087141A1 (en) 2004-10-14
AU2004226821A1 (en) 2004-10-14
CA2521250A1 (en) 2004-10-14
WO2004087141B1 (en) 2005-01-06
US20070276004A1 (en) 2007-11-29
NO20055136L (no) 2006-01-04
RS20050739A (en) 2007-11-15

Similar Documents

Publication Publication Date Title
MXPA05010708A (es) Composicion farmaceutica que comprende un inmunosupresor para utilizarse en el tratamiento de enfermedades de la piel.
DE60121303D1 (de) Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten
WO2008127373A3 (en) Methods and devices for treating tissue
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
WO2002043652A3 (en) Anti-proliferative drugs
WO2005102252A3 (de) Haut- und/oder haarmittel enthaltend verbindungen mit isoprenoider struktur
WO2005000245A3 (en) Compositions and methods for increasing telomerase activity
EP2144608A4 (en) SUN PROTECTION COMPOSITIONS AND METHODS
TW200801031A (en) Steroid nitrooxyderivatives
ATE253939T1 (de) Pharmazeutische zusammensetzung enthaltend einen squalenepoxidasehemmer und einen makrolid- immunomodulator
MX2007005645A (es) Composicion farmaceutica que comprende un inmunomodulador de celulas-t de macrolidos y un agente contra el foto-envejecimiento.
WO2006033713A3 (en) Methods for ciprofloxacin inhalation
WO2007113531A3 (en) Topical drug delivery
WO2004075867A3 (de) Zubereitungen eines extraktes von eperua falcata und/oder dessen inhaltstoffe enthaltend
WO2008050157A3 (en) Ozonated oil formulations
PL2066409T3 (pl) Zastosowanie ekstraktu z quinoa jako kosmetycznego i farmaceutycznego środka czynnego odchudzającego i/lub jako środka czynnego zapobiegającego tworzeniu się nowych tłuszczów w ludzkim ciele
WO2002087533A8 (de) Verwendung von klee-extrakt zur prophylaxe gegen und behandlung von degenerativen hauterscheinungen
WO2004006887A3 (en) Composition and methods for the treatment of skin disorders
MXPA05010704A (es) Composiciones farmaceuticas que comprenden un inmunomodulador de macrolido.
WO2004030623A3 (en) Nitroxide radioprotector formulations and methods of use
AU2002224822A1 (en) Cosmetic skin treatment, care or protection composition
GB0425633D0 (en) Topical formulations for use in the treatment or prevention of dermatological conditions
BRPI0409207A (pt) combinação de um macrolìdeo e um anestésico local para o tratamento de doenças dermatológicas
EP1374832A4 (en) COSMETICS FOR PROMOTING THE RIPENATION OF A HARVEST COVER AND TREATMENT PROCEDURE
AU2003214288A1 (en) Cosmetic composition for treatment against skin ageing